Table 1.
Sociodemograpic | |
---|---|
Age, mean (sd) | 48 (6.4) |
Gender, n (%) | |
Male | 22 (55) |
Female | 18 (45) |
Race, n (%)a | |
White | 15 (39) |
Black | 6 (15) |
Other | 18 (46) |
Ethnicity, n (%)a | |
Hispanic | 30 (77) |
Non-Hispanic | 9 (23) |
Education, n (%) | |
Grade 12/GED or lower | 37 (93) |
College (partial or completed) | 3 (7) |
Marriage Status, n (%) | |
Married/living with partner | 20 (50) |
Widowed/separated/divorced/single | 20 (50) |
Employed, n (%)a | |
Employed | 4 (11) |
Unable to work/unemployed/other | 34 (89) |
Housing status, n (%)a | |
Stable | 31 (82) |
Unstable | 7 (18) |
Psychiatric | |
Psychiatric illness, n (%)b | |
Current psychiatric illness | 26 (65) |
No current psychiatric illness | 14 (35) |
Depression: Beck Depression Inventory-II, n (%) | |
BDI 0-19 (none, minimal or mild) | 19 (48) |
BDI 20-28 (moderate) | 5 (12) |
BDI 29-63 (severe) | 16 (40) |
Drug and Alcohol Use | |
Alcohol (by AUDIT), n (%) | |
At risk alcohol (AUDIT ≥ 8) | 3 (8) |
Not at risk alcohol (AUDIT < 8) | 37 (92) |
Self-reported illicit drug use - past 30 days, n (%) | |
Cocaine/crack within 30 days | 9 (23) |
Heroin within 30 days | 9 (23) |
Any heroin/cocaine/crack within 30 days | 15 (38) |
Years of methadone maintenance, median (IQR) | 10 (5 - 18) |
Median methadone dose - mg, median (IQR) | 90 (60 - 140) |
HCV-related Factors | |
HCV genotype, n (%) | |
Genotype 1 or 4 | 24 (60) |
Genotype 2 | 9 (23) |
Genotype 3 | 7 (17) |
HCV Viral Load (IU/ml), n (%) | |
≥ 800,000 IU/ml | 15 (38) |
< 800,000 IU/ml | 25 (62) |
HIV status, n (%) | |
HIV- | 29 (73) |
HIV+ | 11 (27) |
CD4 (cells/mm3), median (IQR) | 476 (356 - 820) |
Taking HAART, n (%) | 7 (64) |
a missing data
b depression, anxiety disorder, psychotic disorder, post-traumatic stress disorder, and/or bipolar disorder